Legionellahas been reported in 2% to 27% of SOT recipients with pneumonia (76–78).
Most common species implicated are Legionella pneumophila and L. micdadei (79,80). A
prodrome of influenza-like symptoms is followed by a sometimes “explosive” pneumonia
with patchy lobular or interstitial infiltrates on chest radiograph. High fever, hypothermia,
abdominal pain, and mental status changes are sometimes seen. Pneumonia is the most
common presentation, but some patients have just fever (74). Other manifestations have also
been described such as liver abscesses, pericarditis, cellulitis, peritonitis, or hemodialysis
fistula infections (81). Infiltrate is usually lobar, butLegionellahas to be included in the
differential diagnosis of lung nodules, cavitating pneumonia, and lung abscess (71).Legionella
infections can be overlooked unless specialized laboratory methodologies (cultured on
selective media, urinary antigen test) are applied routinely on all cases of pneumonia (72).
Routine culture forLegionellain the water supply is recommended in all transplant centers and
ICUs with cases of legionellosis (82). The use of impregnated filter systems may help prevent
nosocomial legionellosis in high-risk patient care areas (83). Late community-acquired
bacterial pneumonias are 10-fold more frequent in cardiac transplant recipients than in the
general population (2.6 cases/100 cardiac transplants) (64). The etiological agents are similar to
those of the general population (S. pneumoniae, Haemophilus influenzae, etc.), with the exception
of lung transplant patients who may suffer recurrent pneumonias caused by
P. aeruginosaorB. cepacia(84).
The frequency ofM. tuberculosisdisease in receptors of solid-organ transplantation in
most developed countries ranges from 1.2% to 6.4%, but in transplant patients living in areas of
high-level endemicity it might reach up to 15% (38,85–87). Although there is a huge regional
variability, in general, SOT incidence is 20 to 74 times higher than in the general population,
with a mortality rate of up to 30%. The most frequent form of acquisition of tuberculosis after
transplantation is the reactivation of latent tuberculosis in patients with previous exposure.
Tuberculosis develops a mean of 9 months after transplantation (0.5–13 months). Risk factors
for early onset are nonrenal transplant, allograft rejection, immunosuppressive therapy with
OKT3 or anti–T cell antibodies, and previous exposure toM. tuberculosis. Clinical presentation
is frequently atypical and diverse, with unsuspected and elusive sites of involvement. A large
series of tuberculosis in transplant recipients described pulmonary involvement in 51% of
patients, extrapulmonary tuberculosis in 16%, and disseminated infection in 33% (38). In lungs,
radiographic appearance may vary between focal or diffuse interstitial infiltrates, nodules,
pleural effusion, or cavitary lesions. Manifestations include fever of unknown origin, allograft
dysfunction, gastrointestinal bleeding, peritonitis, or ulcers. In transplant patients,
M. tuberculosisinfection was also described in skin, muscle, osteoarticular system, CNS,
genitourinary tract, lymph nodes, larynx, adrenal glands, and thyroid (38,88). Ocular lesions
may be an early way to detect dissemination (59). Coinfection with other pathogens is not
Table 3 Probable Etiology of Pneumonia in Relation to the Type and Progression of the Infiltrates
Radiological
pattern
Probable etiology in relation to the type and progression of the infiltrates
Acutea Subacute
Consolidation Bacteria (S. Pneumoniaegram-negative
rods,Legionella,S. aureus) (1–2 wk)
Embolism, atelectasis
Hemorrhage
Acute graft rejection in lung transplant
recipients
CMV (2–3 m or later if prophylaxis)
Aspergillus(30 days),Nocardia, tuberculosis
(9–23 mo), drugs
P. jiroveci, Legionella,HSV, VZV,Toxoplasma
Bronchiolitis obliterans
Interstitial Edema
Transfusions
(Bacteria)
Virus (CMV, influenza, parainfluenza, RSV,
EBV),P. jiroveci, drugs
(Fungi,Nocardia, tuberculosis)
Nodular (Bacteria, edema) Fungi,Nocardia, R. equi, tuberculosis
(P. jiroveci, CMV)
aRequires attention in<24 hours. Less common possibilities are among brackets.
Infections in Organ Transplants in Critical Care 393